A detailed history of Townsquare Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Townsquare Capital LLC holds 140,683 shares of ABBV stock, worth $24.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
140,683
Previous 138,315 1.71%
Holding current value
$24.9 Million
Previous $23.7 Million 17.11%
% of portfolio
0.34%
Previous 0.33%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $387,973 - $472,013
2,368 Added 1.71%
140,683 $27.8 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $5.59 Million - $6.53 Million
36,119 Added 35.34%
138,315 $23.7 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $446,057 - $508,241
-2,791 Reduced 2.66%
102,196 $18.6 Million
Q4 2023

Feb 15, 2024

SELL
$137.6 - $154.97 $1.14 Million - $1.28 Million
-8,255 Reduced 7.29%
104,987 $16.3 Million
Q3 2023

Nov 15, 2023

SELL
$133.59 - $154.65 $602,223 - $697,162
-4,508 Reduced 3.83%
113,242 $16.9 Million
Q2 2023

Nov 13, 2023

BUY
$132.51 - $164.9 $2.28 Million - $2.84 Million
17,223 Added 17.13%
117,750 $15.9 Million
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $778,724 - $896,817
-5,385 Reduced 5.08%
100,527 $16 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $5.71 Million - $6.84 Million
41,263 Added 63.83%
105,912 $17.1 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $296,738 - $340,339
2,211 Added 3.54%
64,649 $8.68 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $517,588 - $658,024
3,761 Added 6.41%
62,438 $9.56 Million
Q1 2022

Apr 28, 2022

BUY
$131.98 - $163.75 $917,392 - $1.14 Million
6,951 Added 13.44%
58,677 $9.51 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $94,216 - $119,210
-877 Reduced 1.67%
51,726 $7 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $779,912 - $885,317
7,330 Added 16.19%
52,603 $5.68 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $315,630 - $351,630
3,000 Added 7.1%
45,273 $5.24 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $23,938 - $26,353
234 Added 0.56%
42,273 $4.57 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $1.29 Million - $1.74 Million
16,016 Added 61.55%
42,039 $4.5 Million
Q3 2020

Dec 01, 2020

BUY
$85.91 - $100.83 $57,130 - $67,051
665 Added 2.62%
26,023 $2.24 Million
Q2 2020

Aug 17, 2020

SELL
$73.37 - $98.18 $519,753 - $695,507
-7,084 Reduced 21.84%
25,358 $2.48 Million
Q1 2020

May 18, 2020

BUY
$64.5 - $97.79 $210,979 - $319,871
3,271 Added 11.21%
32,442 $2.69 Million
Q4 2019

May 18, 2020

SELL
$72.13 - $90.25 $228,002 - $285,280
-3,161 Reduced 9.78%
29,171 $2.58 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $89,872 - $108,052
1,427 Added 4.62%
32,332 $2.65 Million
Q2 2019

Aug 15, 2019

SELL
$65.7 - $83.98 $599,184 - $765,897
-9,120 Reduced 22.79%
30,905 $2.02 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $1.18 Million - $1.39 Million
15,331 Added 62.08%
40,025 $3.23 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $1.92 Million - $2.37 Million
24,694 New
24,694 $1.97 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.